Amanda Lewin is a Senior Technical Advisor for the Promoting the Quality of Medicines Plus (PQM+) program, focusing on improving medicinal product quality in low- and middle-income countries. With over two years of experience in donor-funded programs and six years of FDA review experience, they have specialized in bioequivalence studies and analytical inspections. Amanda has also led a multidisciplinary team at the FDA and provided technical guidance to strengthen regulatory systems. They hold a PhD in Pharmacology from Georgetown University and have a background in chemistry and forensic toxicology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices